Lactulosum Hasco (Lactulose, Liquid)

Lactulose is a synthetic sugar that reaches the colon unchanged. Colonic bacteria ferment it into short‑chain fatty acids, which increase the osmotic pressure in the intestinal lumen. This draws water into the bowel, softening the stool and speeding transit. The acidic environment also converts ammonia to ammonium, reducing its absorption and benefiting patients with hepatic encephalopathy.

The dose of Lactulosum Hasco is individualized by the prescribing healthcare professional based on the patient’s condition, age, renal function and response. The prescriber determines the volume and frequency of administration, and patients should follow the written instructions without altering the regimen on their own.

Safety data for lactulose during pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case and discuss potential risks with the patient before initiating therapy.

To request Lactulosum Hasco, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lactulose is an osmotic laxative that works by increasing colonic water content, similar to polyethylene glycol (PEG) solutions. Compared with PEG, lactulose also reduces intestinal ammonia, making it the preferred choice for patients with hepatic encephalopathy. PEG generally has a faster onset for pure constipation but lacks the ammonia‑lowering effect.

Lactulosum Hasco should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use. Do not freeze the product, and discard any solution that appears discoloured or contaminated.

Lactulosum Hasco is an oral liquid taken by mouth. The prescribed volume is measured with a calibrated dosing device or syringe, then swallowed directly or mixed with a small amount of water or juice if needed. Doses are usually spaced several hours apart, and the solution can be taken with or without food as directed by the prescriber.

Serious risks, though uncommon, include severe dehydration, marked electrolyte disturbances (especially low potassium), allergic reactions such as rash or swelling, and severe abdominal pain. Patients experiencing persistent watery diarrhea, dizziness, or signs of electrolyte imbalance should seek medical attention promptly.

Lactulosum Hasco is contraindicated in patients with known hypersensitivity to lactulose, complete intestinal obstruction, or severe inflammatory bowel disease that could be aggravated by increased bowel activity. Caution is also advised for individuals with renal impairment, uncontrolled diabetes, or those on medications that may interact significantly with lactulose.